Skip to main content

Table 2 Patients’ clinical manifestations (n = 41)

From: Intrathecal chemotherapy combined with systemic therapy in patients with refractory leptomeningeal metastasis of non-small cell lung cancer: a retrospective study

Clinical Manifestation

No. of patients (%)

Dizziness

27 (65.9%)

Headache

16 (39%)

Limb weakness

7 (17.1%)

Mental status changes

6 (14.6%)

Incontinence

2 (4.9%)

Epilepsy or convulsion

3 (4.6%)

Vision loss

2 (4.9%)

Hearing loss

1 (2.4%)